10.3760/cma.j.cn511693-20220117-00007
滤泡淋巴瘤分子靶向治疗的研究现状
淋巴瘤,滤泡性、分子靶向治疗、抗原,CD20、蛋白酪氨酸激酶类、磷脂酰肌醇3-激酶
46
中国博士后科学基金特别资助项目2018T110557;徐州医科大学附属医院发展基金XYFY2021001;江苏省科技厅自然科学基金面上项目BK20221218;宿迁市血液病学重点实验室建设项目资助M202111;China Special Postdoctoral Science Foundation2018T110557;Development Fund of Affiliated Hospital of Xuzhou Medical UniversityXYFY2021001;Natural Science Foundation of Jiangsu Provincial Science and Technology DepartmentBK20221218;Suqian Key Laboratory of Hematology Construction Project FundingM202111
2024-01-30(万方平台首次上网日期,不代表论文的发表时间)
共8页
93-100